SPINOCEREBELLAR ATAXIA 31 (disorder)
|
0.630 |
GeneticVariation
|
disease |
BEFREE |
In SCA31 human brains, (UGGAA)<sub>n</sub>, the BEAN1 transcript of SCA31 mutation was found to form abnormal RNA structures called RNA foci in cerebellar Purkinje cell nuclei.
|
31755042 |
2019 |
SPINOCEREBELLAR ATAXIA 31 (disorder)
|
0.630 |
Biomarker
|
disease |
BEFREE |
Taking these findings together, we conclude that the RNA foci containing BEAN1-direction transcript (UGGAA)n are associated with PC degeneration in SCA31.
|
23607545 |
2013 |
SPINOCEREBELLAR ATAXIA 31 (disorder)
|
0.630 |
GeneticVariation
|
disease |
BEFREE |
Spinocerebellar ataxia type 31 (SCA31) is defined by the presence of an insertion mutation containing a TGGAA repeat within the intron of the brain-expressed, associated with NEDD4 (BEAN) gene.
|
22992774 |
2012 |
SPINOCEREBELLAR ATAXIA 31 (disorder)
|
0.630 |
GermlineCausalMutation
|
disease |
ORPHANET |
Spinocerebellar ataxia type 31 (SCA31) is defined by the presence of an insertion mutation containing a TGGAA repeat within the intron of the brain-expressed, associated with NEDD4 (BEAN) gene.
|
22992774 |
2012 |
SPINOCEREBELLAR ATAXIA 31 (disorder)
|
0.630 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
"Spinocerebellar ataxia type 31 is associated with ""inserted"" penta-nucleotide repeats containing (TGGAA)n."
|
19878914 |
2009 |
SPINOCEREBELLAR ATAXIA 31 (disorder)
|
0.630 |
GermlineCausalMutation
|
disease |
ORPHANET |
"Spinocerebellar ataxia type 31 is associated with ""inserted"" penta-nucleotide repeats containing (TGGAA)n."
|
19878914 |
2009 |
SPINOCEREBELLAR ATAXIA 31 (disorder)
|
0.630 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
"Spinocerebellar ataxia type 31 is associated with ""inserted"" penta-nucleotide repeats containing (TGGAA)n."
|
19878914 |
2009 |
SPINOCEREBELLAR ATAXIA 31 (disorder)
|
0.630 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
"Spinocerebellar ataxia type 31 is associated with ""inserted"" penta-nucleotide repeats containing (TGGAA)n."
|
19878914 |
2009 |
SPINOCEREBELLAR ATAXIA 31 (disorder)
|
0.630 |
GermlineCausalMutation
|
disease |
ORPHANET |
Redefining the disease locus of 16q22.1-linked autosomal dominant cerebellar ataxia.
|
17611710 |
2007 |
SPINOCEREBELLAR ATAXIA 31 (disorder)
|
0.630 |
Biomarker
|
disease |
CTD_human |
|
|
|
Ataxia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Dysarthria
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Muscle Spasticity
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Nystagmus
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Tremor
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Hyporeflexia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Cerebellar atrophy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Ataxia, Appendicular
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Gait Ataxia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Decreased vibratory sense
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
hearing impairment
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Hyperactive deep tendon reflexes
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Gaze-evoked horizontal nystagmus
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Nystagmus, CTCAE 3.0
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Spasticity, CTCAE
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|